Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Pulendran: Protective humoral responses against HIV |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2013-10-21 |
| Study Made Public: | 2018-10-18 |
Title
Programming the magnitude and durability of HIV-1 clade C 1086.C envelope specific antibody responses in rhesus macaques with a novel TLR-7/8 agonist (3M-052) formulated with or without a TLR-4 agonist (GLA) in biodegradable poly (lactic-co-glycolic acid), PLGA nanoparticles
Description
CAVD 432 is a non-human primate study of protein and adjuvant regimens.
Sign in to see full information about this study and to download study data.
Products
Alum gp140 (1086C) PLGA (MPL) PLGA (R848) PLGA (3M-052) PGLA (GLA)Integrated data
BAMA, NAb
Non-integrated data
No non-integrated data is available for this study.